Mm. Thurnher et al., Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy, AM J NEUROR, 22(5), 2001, pp. 977-984
Citations number
26
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Neurosciences & Behavoir
BACKGROUND AND PURPOSE: Recent studies have Shown the beneficial effect of
highly active antiretroviral therapy (HAART) in AIDS-related progressive mu
ltifocal leukoencephalopathy (PML). The purpose of our study was to evaluat
e the initial and follow-up imaging findings and survival in patients with
PML who were treated with HAART.
METHODS: The clinical course and MR imaging findings on initial and follow-
up MR studies in four consecutive AIDS patients with PML who were treated w
ith HAART are described.
RESULTS: Two patients were short-term survivors and died after 3 months, Tw
o patients are still alive, with a survival time of 22 and 43 months, respe
ctively, On initial MR studies, more extensive white matter changes were se
en in the short-term survivors. Development of a mass effect and temporary
enhancement (in one patient) was observed in two HAART responders on follow
-up MR studies, Increased hypointensity on T1-weighted images with concomit
ant low signal on fluid-attenuated inversion-recovery fast spin-echo (FLAIR
-FSE) images was seen in two responders, representing leukomalacia, Atrophi
c changes of the involved areas of the brain, consistent with burnt out PML
lesions, were seen in two long-term survivors, In the short-term survivors
, increased hypointensity was present on TI-weighted images with increased
high signal on FLAIR-FSE images, representing progressive destructive disea
se,
CONCLUSION: Our results suggest that a clinical and radiologic response can
be seen in some patients with AIDS-associated PML on HAART while in others
there may be no beneficial response. Development of a mass effect and temp
orary enhancement on MR images in the early phase of treatment might repres
ent positive predictive factors for prolonged survival.